115 related articles for article (PubMed ID: 18413774)
21. HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.
Press MF; Finn RS; Cameron D; Di Leo A; Geyer CE; Villalobos IE; Santiago A; Guzman R; Gasparyan A; Ma Y; Danenberg K; Martin AM; Williams L; Oliva C; Stein S; Gagnon R; Arbushites M; Koehler MT
Clin Cancer Res; 2008 Dec; 14(23):7861-70. PubMed ID: 19047115
[TBL] [Abstract][Full Text] [Related]
22. Biological markers and prognosis in recurrent oral cancer after salvage surgery.
Agra IM; Carvalho AL; Pinto CA; Martins EP; Filho JG; Soares FA; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):743-9. PubMed ID: 18645125
[TBL] [Abstract][Full Text] [Related]
23. Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer.
Tsuchiya N; Wang L; Suzuki H; Segawa T; Fukuda H; Narita S; Shimbo M; Kamoto T; Mitsumori K; Ichikawa T; Ogawa O; Nakamura A; Habuchi T
J Clin Oncol; 2006 May; 24(13):1982-9. PubMed ID: 16648498
[TBL] [Abstract][Full Text] [Related]
24. Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer.
Arnes JB; Bégin LR; Stefansson I; Brunet JS; Nielsen TO; Foulkes WD; Akslen LA
J Clin Pathol; 2009 Feb; 62(2):139-46. PubMed ID: 18682421
[TBL] [Abstract][Full Text] [Related]
25. Biological importance of a polymorphic CA sequence within intron 1 of the epidermal growth factor receptor gene (EGFR) in high grade central osteosarcomas.
Kersting C; Agelopoulos K; Schmidt H; Korsching E; August C; Gosheger G; Dirksen U; Juergens H; Winkelmann W; Brandt B; Bielack S; Buerger H; Gebert C
Genes Chromosomes Cancer; 2008 Aug; 47(8):657-64. PubMed ID: 18464244
[TBL] [Abstract][Full Text] [Related]
26. No association between epidermal growth factor and epidermal growth factor receptor polymorphisms and nasopharyngeal carcinoma.
Gao LB; Wei YS; Zhou B; Wang YY; Liang WB; Li C; Li Y; Bai P; Fang WL; Xue H; Zhang L
Cancer Genet Cytogenet; 2008 Sep; 185(2):69-73. PubMed ID: 18722874
[TBL] [Abstract][Full Text] [Related]
27. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
De Feo E; Persiani R; La Greca A; Amore R; Arzani D; Rausei S; D'Ugo D; Magistrelli P; van Duijn CM; Ricciardi G; Boccia S
Mutat Res; 2009 Apr; 675(1-2):60-5. PubMed ID: 19386249
[TBL] [Abstract][Full Text] [Related]
28. Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer.
Derin D; Eralp Y; Ozluk Y; Yavuz E; Guney N; Saip P; Igci A; Ozmen V; Kücücük S; Aslay I; Aydiner A; Topuz E
Cancer Invest; 2008 Aug; 26(7):671-9. PubMed ID: 18608215
[TBL] [Abstract][Full Text] [Related]
29. Decreased survival in EGFR gene amplified vulvar carcinoma.
Growdon WB; Boisvert SL; Akhavanfard S; Oliva E; Dias-Santagata DC; Kojiro S; Horowitz NS; Iafrate AJ; Borger DR; Rueda BR
Gynecol Oncol; 2008 Nov; 111(2):289-97. PubMed ID: 18768215
[TBL] [Abstract][Full Text] [Related]
30. Predicting skin toxicity according to EGFR polymorphisms in patients with colorectal cancer receiving antibody against EGFR.
Saito R; Suzuki H; Yamada T; Endo S; Moriwaki T; Ueno T; Hirose M; Hirai S; Yamato K; Mizokami Y; Hyodo I
Anticancer Res; 2013 Nov; 33(11):4995-8. PubMed ID: 24222141
[TBL] [Abstract][Full Text] [Related]
31. GSTM, GSTT and p53 polymorphisms as modifiers of clinical outcome in colorectal cancer.
Csejtei A; Tibold A; Varga Z; Koltai K; Ember A; Orsos Z; Feher G; Horvath OP; Ember I; Kiss I
Anticancer Res; 2008; 28(3B):1917-22. PubMed ID: 18630481
[TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor receptor gene polymorphisms are associated with prognostic features of breast cancer.
Leite MS; Giacomin LC; Piranda DN; Festa-Vasconcellos JS; Indio-do-Brasil V; Koifman S; de Moura-Neto RS; de Carvalho MA; Vianna-Jorge R
BMC Cancer; 2014 Mar; 14():190. PubMed ID: 24629097
[TBL] [Abstract][Full Text] [Related]
33. Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.
Sasaki H; Shimizu S; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
Lung Cancer; 2009 Jun; 64(3):295-300. PubMed ID: 19058870
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma.
Idbaih A; Aimard J; Boisselier B; Marie Y; Paris S; Crinière E; Carvalho Silva R; Laigle-Donadey F; Rousseau A; Mokhtari K; Thillet J; Sanson M; Hoang-Xuan K; Delattre JY
Neuropathol Appl Neurobiol; 2009 Apr; 35(2):208-13. PubMed ID: 19284481
[TBL] [Abstract][Full Text] [Related]
35. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
[TBL] [Abstract][Full Text] [Related]
36. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival.
Wrensch M; Wiencke JK; Wiemels J; Miike R; Patoka J; Moghadassi M; McMillan A; Kelsey KT; Aldape K; Lamborn KR; Parsa AT; Sison JD; Prados MD
Cancer Res; 2006 Apr; 66(8):4531-41. PubMed ID: 16618782
[TBL] [Abstract][Full Text] [Related]
37. K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.
Etienne-Grimaldi MC; Formento JL; Francoual M; François E; Formento P; Renée N; Laurent-Puig P; Chazal M; Benchimol D; Delpero JR; Letoublon C; Pezet D; Seitz JF; Milano G
Clin Cancer Res; 2008 Aug; 14(15):4830-5. PubMed ID: 18676755
[TBL] [Abstract][Full Text] [Related]
38. Association of an EGFR intron 1 SNP with never-smoking female lung adenocarcinoma patients.
Jou YS; Lo YL; Hsiao CF; Chang GC; Tsai YH; Su WC; Chen YM; Huang MS; Chen HL; Chen CJ; Yang PC; Hsiung CA
Lung Cancer; 2009 Jun; 64(3):251-6. PubMed ID: 19026460
[TBL] [Abstract][Full Text] [Related]
39. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.
Vaccaro CA; Im V; Rossi GL; Quintana GO; Benati ML; Perez de Arenaza D; Bonadeo FA
Dis Colon Rectum; 2009 Jul; 52(7):1244-50. PubMed ID: 19571700
[TBL] [Abstract][Full Text] [Related]
40. Pharmacogenetic profiling of Aurora kinase B is associated with overall survival in metastatic colorectal cancer.
Pohl A; Azuma M; Zhang W; Yang D; Ning Y; Winder T; Danenberg K; Lenz HJ
Pharmacogenomics J; 2011 Apr; 11(2):93-9. PubMed ID: 20368716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
